Middle East

The FDA Middle East Office is responsible for FDA’s bilateral and multilateral interactions with the countries of North Africa and the broader Middle East. The Middle East Office’s goal is to ensure that the entire range of FDA-regulated products that are developed, tested, manufactured, grown and/or processed from this region and exported to the United States meet the highest standards of quality and safety. Building strong, close collaborative relationships and strengthening capacities within the region will be a prime focus of this office. The Office does not yet have a physical presence in the region, but plans to establish a regional headquarters in the near future. Staff are currently located at FDA headquarters in Rockville, Maryland.

The work of the Office will be accomplished in conjunction with FDA’s regulatory and public health counterparts in each country of the region, with health organizations, industrial and trade groups, universities and training centers, our U.S. Government counterparts (e.g, U.S. Departments of Agriculture, Commerce and Homeland Security, the Centers for Disease Control and Prevention and others within the U.S. Department of Health and Human Services), and embassies in Washington, D.C. Initiatives and activities will be centered on building capacity, harmonizing standards, and strengthening and facilitating interactions with FDA experts in its product centers, and field offices in the United States.

More About the Office Activities »